1. Home
  2. BOSC vs SCYX Comparison

BOSC vs SCYX Comparison

Compare BOSC & SCYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOSC
  • SCYX
  • Stock Information
  • Founded
  • BOSC 1990
  • SCYX 1999
  • Country
  • BOSC Israel
  • SCYX United States
  • Employees
  • BOSC N/A
  • SCYX N/A
  • Industry
  • BOSC Computer Communications Equipment
  • SCYX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOSC Telecommunications
  • SCYX Health Care
  • Exchange
  • BOSC Nasdaq
  • SCYX Nasdaq
  • Market Cap
  • BOSC 28.4M
  • SCYX 28.5M
  • IPO Year
  • BOSC 1996
  • SCYX 2014
  • Fundamental
  • Price
  • BOSC $5.01
  • SCYX $0.71
  • Analyst Decision
  • BOSC
  • SCYX
  • Analyst Count
  • BOSC 0
  • SCYX 0
  • Target Price
  • BOSC N/A
  • SCYX N/A
  • AVG Volume (30 Days)
  • BOSC 134.5K
  • SCYX 145.5K
  • Earning Date
  • BOSC 08-21-2025
  • SCYX 08-07-2025
  • Dividend Yield
  • BOSC N/A
  • SCYX N/A
  • EPS Growth
  • BOSC 35.10
  • SCYX N/A
  • EPS
  • BOSC 0.49
  • SCYX N/A
  • Revenue
  • BOSC $43,688,000.00
  • SCYX $2,630,000.00
  • Revenue This Year
  • BOSC N/A
  • SCYX $463.61
  • Revenue Next Year
  • BOSC N/A
  • SCYX $310.80
  • P/E Ratio
  • BOSC $10.28
  • SCYX N/A
  • Revenue Growth
  • BOSC 0.84
  • SCYX N/A
  • 52 Week Low
  • BOSC $2.50
  • SCYX $0.66
  • 52 Week High
  • BOSC $5.50
  • SCYX $2.29
  • Technical
  • Relative Strength Index (RSI)
  • BOSC 56.60
  • SCYX 38.69
  • Support Level
  • BOSC $4.66
  • SCYX $0.67
  • Resistance Level
  • BOSC $5.20
  • SCYX $0.75
  • Average True Range (ATR)
  • BOSC 0.22
  • SCYX 0.04
  • MACD
  • BOSC -0.02
  • SCYX 0.00
  • Stochastic Oscillator
  • BOSC 50.00
  • SCYX 33.06

About BOSC B.O.S. Better Online Solutions

BOS Better Online Solutions Ltd is a provider of Intelligent Robotics and Supply Chain solutions for enterprises. The company manages its business in three reportable divisions: the Intelligent Robotics segment, the RFID Division segment, and the Supply Chain Solutions segment. The majority of revenue derives from Supply Chain Solutions which distributes electro-mechanical components, mainly to customers in the aerospace, defense, and other industries, and is a supply chain service provider for aviation customers that seek a comprehensive solution to their components-supply needs. Geographically company derives the majority of its revenue from Israel.

About SCYX SCYNEXIS Inc.

SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.

Share on Social Networks: